List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 177 studies with search of: prostate cancer AND new jersey
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Completed Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Transdermal Estradiol
2 Recruiting Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: atorvastatin calcium;   Drug: celecoxib;   Other: laboratory biomarker analysis
3 Recruiting Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate Cancer
Condition: Prostate Cancer
Interventions: Dietary Supplement: vitamin E;   Procedure: sham intervention
4 Recruiting Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097;   Other: placebo
5 Recruiting Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors or Prostate or Kidney Cancer
Conditions: Kidney Cancer;   Prostate Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: Akt inhibitor MK2206;   Drug: hydroxychloroquine;   Other: laboratory biomarker analysis;   Other: pharmacological study
6 Completed Etoposide and Cyclophosphamide in Treating Patients With Stage D0 Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: cyclophosphamide;   Drug: etoposide
7 Completed Transdermal Estradiol in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy and Chemotherapy
Condition: Prostate Cancer
Intervention: Biological: therapeutic estradiol
8 Completed Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Etoposide;   Drug: Cyclophosphamide
9 Suspended Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: docetaxel;   Drug: hydroxychloroquine
10 Active, not recruiting Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: hydroxychloroquine
11 Active, not recruiting Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia
Conditions: Precancerous/Nonmalignant Condition;   Prostate Cancer
Interventions: Dietary Supplement: calcitriol;   Procedure: observation
12 Terminated Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
Condition: Prostate Cancer
Interventions: Dietary Supplement: licorice root extract;   Drug: docetaxel
13 Terminated Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
Condition: Prostate Cancer
Interventions: Biological: recombinant interferon alfa-2b;   Drug: docetaxel;   Drug: estramustine phosphate sodium;   Drug: isotretinoin;   Genetic: polyacrylamide gel electrophoresis;   Genetic: protein expression analysis;   Other: immunohistochemistry staining method
14 Completed Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among Elderly
Condition: Prostate Cancer
Intervention:
15 Completed Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer
Conditions: Osteoporosis;   Prostate Cancer
Intervention: Procedure: dual x-ray absorptiometry
16 Active, not recruiting Gossypol and Androgen Ablation Therapy in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: R-(-)-gossypol acetic acid
17 Terminated A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: 2-deoxyglucose
18 Terminated Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer
Conditions: Lung Cancer;   Malnutrition;   Pancreatic Cancer;   Prostate Cancer;   Weight Changes
Interventions: Behavioral: compliance monitoring;   Dietary Supplement: dietary intervention;   Dietary Supplement: nutritional intervention;   Drug: chemotherapy;   Other: counseling intervention;   Other: medical chart review;   Other: questionnaire administration;   Other: study of socioeconomic and demographic variables;   Procedure: management of therapy complications;   Procedure: observation;   Procedure: quality-of-life assessment
19 Completed Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate
Condition: Prostate Cancer
Intervention:
20 Completed Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors
Conditions: Breast Cancer;   Colorectal Cancer;   Head and Neck Cancer;   Lung Cancer;   Melanoma (Skin);   Ovarian Cancer;   Pancreatic Cancer;   Prostate Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: bortezomib;   Drug: paclitaxel

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services